Drug allergy pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
**[[procainamide]]
**[[procainamide]]
**[[halothane]]
**[[halothane]]
===Specific Reaction Types===


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 18:34, 14 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]

Drug Allergy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Drug allergy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Drug allergy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Drug allergy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Drug allergy pathophysiology

CDC on Drug allergy pathophysiology

Drug allergy pathophysiology in the news

Blogs on Drug allergy pathophysiology

Directions to Hospitals Treating Drug allergy

Risk calculators and risk factors for Drug allergy pathophysiology

Overview

Medications can cause allergic reactions through various mechanisms. The drug can either act as a direct antigenic particle, or it can cause activation of immune cells by the direct interaction with immune cell receptors.

Pathophysiology

Drugs Acting as Antigens

Most drugs do not act as antigenic particles in their mature form. This is because they are usually small, and therefore not recognized by immune receptors enough to actually activate T cells or B cells. However, drugs can act as antigens if they are presented to lymphocytes by antigen presenting cells such as dendrites. This response specific to the drug can be solely T-cell mediated, antibody mediated, or can have components of both.

  • Stimulation of the antibody response- In general, antigens are processed by antigen presenting cells and presented to T-cells. This leads to t-cell activation and produces cytokines which then activate B cells. B cells then recognize the antigen through its IgG receptor, and becomes activated subsequently producing antigen-specific immunoglobulins. Modern pharmaceuticals that are proteins or resemble proteins, can stimulate antibody and T cell responses similar to other protein antigens. Examples of drugs that cause this type of reaction are:

Some of these compounds can induce antibody formation without any T cell interaction.

  • Drugs as haptens or pro-haptens- Small drugs can become immunogenic by binding covalently to larger macromolecules such as host proteins on cell surfaces or in plasma. The drug is then called a hapten, and the antigenic compound is then called a hapten-carrier complex. These complexes can also induce a a T cell and antibody response. Drugs that give rise to metabolites that can act as haptens are called pro-haptens. For example, penecillin often acts as a hapten when the beta-lactam ring breaks open and reacts with lysine to form a hapten-carrier complex called penecilloyl determinant, which is capable of stimulating T-cells and antibodies [1] [2]. A few drugs which have this capability are
    • penecillin and other beta-lactam antibiotics
    • penecillamine
    • gold and other heavy metals
  • Reactive metabolites- Some drugs may not be reactive with macromolecules in their original state, however may form reactive particles after undergoing metabolism by CYP450 enzymes. As part of drug metabolism by hepatocytes, some drugs may not undergo correct detoxification and bind to or haptenate intracellular proteins. [3] Alternatively, they may be excreted by the cell and processed by antigen presenting cells. These antigen presenting cells can then present the drug on the surface of the cells to T cells. T cells would then produce cytokines and to stimulate B cells, and both T cell and antibody mediated responses would then occur. Glutathione usually neutralizes drugs that give rise to intermediates during metabolism. Some drugs escape neutralization. Examples of these drugs are:

Specific Reaction Types

References

  1. Lafaye P, Lapresle C (1988). "Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients". J. Clin. Invest. 82 (1): 7–12. doi:10.1172/JCI113603. PMC 303468. PMID 3392217. Unknown parameter |month= ignored (help)
  2. Padovan E (1998). "T-cell response in penicillin allergy". Clin. Exp. Allergy. 28 Suppl 4: 33–6. PMID 9761028. Unknown parameter |month= ignored (help)
  3. Meekins CV, Sullivan TJ, Gruchalla RS (1994). "Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins". J. Allergy Clin. Immunol. 94 (6 Pt 1): 1017–24. PMID 7798534. Unknown parameter |month= ignored (help)